Texas · 19283

Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth in Texas

Texas Medicare Avg
$85.77
13% below national avg
National Medicare Avg
$99.04
All states combined
Billed Charge (TX)
$741.40
What providers submit
Est. Commercial (TX)
$250.78
National avg: $282.93
Est. Cash / Self-Pay (TX)
$285.66
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

171
Services in TX
71
Providers
N/A
Min Payment
N/A
Max Payment

Texas Pricing in Context

In Texas, CPT code 19283 (Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth) carries an average Medicare payment of $85.77 — 13% below the national benchmark of $99.04. 71 providers across the state submitted claims for this procedure in 2023, performing 171 total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $741.40, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Texas lands near $250.78, with self-pay cash prices typically around $285.66. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth cost in Texas?

The average Medicare payment for Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth in Texas is $85.77, which is 13% below the national average of $99.04. Providers in TX typically bill $741.40 for this procedure.

What does Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth cost with insurance in Texas?

With commercial insurance in Texas, Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth costs an estimated $250.78. Without insurance, the estimated cash price is $285.66. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth in Texas?

71 providers in Texas billed Medicare for Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth in 2023, performing 171 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth cheaper in Texas than the national average?

Yes — Placement Of Locating Device In Breast Using X-Ray With Needle Guidance, First Growth costs 13% below the national average in Texas. The state average Medicare payment is $85.77 compared to $99.04 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial